A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.

作者: Rong Chen , Chana Hecht , Nelson Gruszczynski , Wesley J. Yon , Denis Malyshev

DOI: 10.1126/SCIADV.AAV6528

关键词:

摘要: Colorectal cancer remains a leading source of cancer … , reflecting currently undruggable cancer drivers such as KRAS … metastatic KRAS-mutant colorectal cancer. An extensive genomic …

参考文章(55)
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio Garcia-Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Eveline Boucher, Marc Peeters, Ben Tran, Heinz-Josef Lenz, Alberto Zaniboni, Howard Hochster, James M Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu, None, Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer The New England Journal of Medicine. ,vol. 372, pp. 1909- 1919 ,(2015) , 10.1056/NEJMOA1414325
Jean-Philippe Vert, Nicolas Foveau, Christian Lajaunie, Yves Vandenbrouck, An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics. ,vol. 7, pp. 520- 520 ,(2006) , 10.1186/1471-2105-7-520
Andrea L. Russo, Darrell R. Borger, Jackie Szymonifka, David P. Ryan, Jennifer Y. Wo, Lawrence S. Blaszkowsky, Eunice L. Kwak, Jill N. Allen, Raymond C. Wadlow, Andrew X. Zhu, Janet E. Murphy, Jason E. Faris, Dora Dias-Santagata, Kevin M. Haigis, Leif W. Ellisen, Anthony J. Iafrate, Theodore S. Hong, Mutational analysis and clinical correlation of metastatic colorectal cancer. Cancer. ,vol. 120, pp. 1482- 1490 ,(2014) , 10.1002/CNCR.28599
G. I Meling, P Laurent-Puig, B. J Iacopetta, R Glaesener, O. P. F Clausen, F Al-Mulla, W Giaretti, V. J Bubb, A. F. P. M de Goeij, G Gaudernack, T Ohkusa, P Quirke, A Rapallo, N Hawkins, R Rosell, T. O Rognum, S. N Andersen, R Smith, J Costa, R Ward, I Hoffmann, T Fujimori, D Cunningham, D Morton, C. T Croke, J Oates, X. F Sun, S Bell, P. A Clarke, S. T Wang, J Breivik, O Muller, A. R Norman, J. W Arends, M Pauly, D Dillon, H. J. N Andreyev, S. D Finkelstein, A. J Senagore, C. N Hall, K Wilkinson, N Lees, N. R Cruickshank, H. S Goh, D Snary, E Jullian, C Valavanis, L Losi, A Russo, H. M Rabes, J Piris, S Wadler, Y Ono, T Azuma, A Font, C Zietz, M Beranek, J. C Fox, S. A Halter, R Benamouzig, B. R Dix, H Zhang, C Faber, K Omura, V. E Pricolo, C Troungos, K Krtolica, J Benhattar, J. W. C Ho, N. Urosevic, T Lovig, D. P O'Donoghue, J. S Thebo, P De Angelis, J. Q Lee, J Young, Bazan, P Jandik, S Olschwang, S. T Yuen, T Walsh, S Malik, M Tanaka, Kirsten ras mutations in patients with colorectal cancer : the ‘RASCAL II’ study Faculty of Health; Institute of Health and Biomedical Innovation. ,vol. 85, pp. 692- 696 ,(2001)
Georgios Karagkounis, Michael S. Torbenson, Hubert D. Daniel, Nilofer S. Azad, Luis A. Diaz, Ross C. Donehower, Kenzo Hirose, Nita Ahuja, Timothy M. Pawlik, Michael A. Choti, Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases Cancer. ,vol. 119, pp. 4137- 4144 ,(2013) , 10.1002/CNCR.28347
Huanbiao Mo, Charles E. Elson, Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Experimental Biology and Medicine. ,vol. 229, pp. 567- 585 ,(2004) , 10.1177/153537020422900701
Scott M. Wilhelm, Jacques Dumas, Lila Adnane, Mark Lynch, Christopher A. Carter, Gunnar Schütz, Karl-Heinz Thierauch, Dieter Zopf, Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity International Journal of Cancer. ,vol. 129, pp. 245- 255 ,(2011) , 10.1002/IJC.25864
Jian-Quan Ni, Rui Zhou, Benjamin Czech, Lu-Ping Liu, Laura Holderbaum, Donghui Yang-Zhou, Hye-Seok Shim, Rong Tao, Dominik Handler, Phillip Karpowicz, Richard Binari, Matthew Booker, Julius Brennecke, Lizabeth A Perkins, Gregory J Hannon, Norbert Perrimon, A genome-scale shRNA resource for transgenic RNAi in Drosophila Nature Methods. ,vol. 8, pp. 405- 407 ,(2011) , 10.1038/NMETH.1592
Tony Yuen, Agnes Stachnik, Jameel Iqbal, Miriam Sgobba, Yogesh Gupta, Ping Lu, Graziana Colaianni, Yaoting Ji, Ling-Ling Zhu, Se-Min Kim, Jianhua Li, Peng Liu, Sudeh Izadmehr, Jaya Sangodkar, Jack Bailey, Yathin Latif, Shiraz Mujtaba, Solomon Epstein, Terry F. Davies, Zhuan Bian, Alberta Zallone, Aneel K. Aggarwal, Shozeb Haider, Maria I. New, Li Sun, Goutham Narla, Mone Zaidi, Bisphosphonates inactivate human EGFRs to exert antitumor actions Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 17989- 17994 ,(2014) , 10.1073/PNAS.1421410111
Gerald S Falchook, Karl D Lewis, Jeffrey R Infante, Michael S Gordon, Nicholas J Vogelzang, Douglas J DeMarini, Peng Sun, Christopher Moy, Stephen A Szabo, Lori T Roadcap, Vijay GR Peddareddigari, Peter F Lebowitz, Ngocdiep T Le, Howard A Burris, Wells A Messersmith, Peter J O'Dwyer, Kevin B Kim, Keith Flaherty, Johanna C Bendell, Rene Gonzalez, Razelle Kurzrock, Leslie A Fecher, Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Lancet Oncology. ,vol. 13, pp. 782- 789 ,(2012) , 10.1016/S1470-2045(12)70269-3